Nautilus Biotechnology, Inc. (NAUT)

2.7800 +0.2400 (+9.45%) At close: 04:00PM EDT

Nautilus Biotechnology, Inc.

2701 Eastlake Avenue East
Seattle, WA 98102
United States
206 333 2001
https://www.nautilus.bio

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 167

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Sujal M. Patel	Co-Founder, CEO, President, Secretary & Director	827.24k	N/A	1975
Dr. Parag Mallick Ph.D.	Co-Founder, Chief Scientist & Director	562.8k	N/A	1978
Ms. Anna Mowry	CFO & Treasurer	519.21k	N/A	1984
Ms. Mary E. Godwin	Senior Vice President of Operations	N/A	N/A	1959
Mr. Matthew B. Murphy ESQ.	General Counsel	382.64k	N/A	1965
Mr. Chris Blessington	Vice President of Corporate Marketing & Communications	N/A	N/A	N/A
Ms. Gwen E. Weld	Chief People Officer	390.97k	N/A	1958
Mr. Nick A. Nelson	Chief Business Officer & Senior VP of Business Development	N/A	N/A	1984
Dr. Subra Sankar Ph.D.	Senior Vice President of Product Development	38.47k	N/A	1960

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Corporate governance

Nautilus Biotechnology, Inc.’s ISS governance QualityScore as of 29 April 2024 is 8. The pillar scores are Audit: 8; Board: 5; Shareholder rights: 8; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.